Welcome to the Department of Medicine
MORE »
Welcome to the Department of Medicine of Weill Cornell Medical College and NewYork-Presbyterian Hospital/Weill Cornell Medical Center. We are responding to the unprecedented challenges of academic medicine at the beginning of the 21st century with an uncompromising commitment to leadership and innovation in our interdependent missions of patient care, education and research. This commitment is built on the foundation of a long and rich tradition of preeminence in American medicine.
Chair of Medicine's New Year's Letter (click here)
State of the Department Presentation 2012 (click here)
Annual Report 2011
The Annual Report provides an in-depth view of the Department of Medicine's latest news in patient care services, breakthrough research, innovative educational programs for residents and fellows, Honors, Awards and a Financial Report. (click here)
Residency Training Program in Internal Medicine
The Department of Medicine is home to one of the premiere internal medicine residency program in the country. (click here)
Historical Tours of Medicine
View our interactive timelines. The first installments covers advances in Vascular Biology and Clinical Pharmacology. More divisions coming soon. Take the Historical Tour
Clinical Trials
Are you a patient or healthy volunteer looking to join a research study? Click here for a complete list of clinical trials in the Department of Medicine.
News & Highlights
Dr. Leonard Named Chair of the Lymphoma Committee for NIH-Sponsored Alliance for Clinical Trials in Oncology
Dr. John P. Leonard, Richard T. Silver Distinguished Professor of Hematology and Medical Oncology and Vice Chair for Clinical Research in the Department of Medicine, was named Chair of the Lymphoma Committee (NIH-Sponsored Alliance for Clinical Trials in Oncology). He will guide the national agenda for lymphoma research regarding Phase II and Phase III NIH-funded clinical trials. Directing a team of clinical and translational researchers from U.S. academic and community medical centers, efforts are focused on creating and implementing new standards of treatment and fostering novel therapeutics. Read More
Dr. Jacobson and Team Published in The New England Journal of Medicine on Sofosbuvir Therapy for Hepatitis C Genotype 2 or 3
An internationally-recognized leader in the field of hepatitis C, Dr. Ira M. Jacobson (Chief, Division of Gastroenterology and Hepatology) has been at the forefront of hepatitis C for more than 20 years. His research has included numerous advances regarding therapies, often involving interferon. As of 2013, he and his team have uncovered another groundbreaking discovery - published in The New England Journal of Medicine, April 13, 2013 -- showing that the new sofosbuvir therapy offers an alternative to standard therapy with interferon for the treatment of two subtypes of hepatitis C. "We have dreamed for years of being able to eliminate interferon from our hepatitis C regimens and this study is one of several that are finally bringing us very close to realizing that goal," says Dr. Jacobson.
Read More
Dr. Lewis Cantley Receives $3 Million Breakthrough Prize in Life Sciences
For excellence in cancer research, Dr. Lewis Cantley, the Margaret and Herman Sokol Professor in Oncology Research and Professor of Cancer Biology in Medicine, received an Inaugural $3 Million Breakthrough Prize in Life Sciences. The award was given to Dr. Cantley for his landmark discovery of the signaling pathway phosphoinositide 3-kinase (PI3K). Read the New York Times Article
Honors & Awards
Marcus M. Reidenberg Award in Community Service Established
Dr. Marcus M. Reidenberg, Professor of Medicine, Pharmacology, and Public Health, and Chief of the Division of Clinical Pharmacology, was recently honored by the Weill Cornell Office of Community Service and Student Affairs with the creation of the Marcus M. Reidenberg Award in Community Service. Upon hearing of the creation of the Award, he said, "It is always thrilling for a teacher to get this kind of acknowledgement from one's students. I feel very honored and appreciative of this award's naming." Read More